Hypotriglyceridemias/hypolipidemias.
Martínez-Hervás S, Real-Collado JT, Ascaso-Gimilio JF.
Clin Investig Arterioscler. 2021 May;33 Suppl 2:63-68. doi: 10.1016/j.arteri.2020.12.011.
Guidance for the diagnosis and treatment of hypolipidemia disorders.
Bredefeld C, Hussain MM, Averna M, Black DD, Brin MF, Burnett JR, Charrière S, Cuerq C, Davidson NO, Deckelbaum RJ, Goldberg IJ, Granot E, Hegele RA, Ishibashi S, Karmally W, Levy E, Moulin P, Okazaki H, Poinsot P, Rader DJ, Takahashi M, Tarugi P, Traber MG, Di Filippo M, Peretti N.
J Clin Lipidol. 2022 Nov-Dec;16(6):797-812. doi: 10.1016/j.jacl.2022.08.009. Epub 2022 Sep 29.
Hypocholesterolemia.
Moutzouri E, Elisaf M, Liberopoulos EN.
Curr Vasc Pharmacol. 2011 Mar;9(2):200-12. doi: 10.2174/157016111794519354.
Neuroacanthocytosis syndromes.
Jung HH, Danek A, Walker RH.
Orphanet J Rare Dis. 2011 Oct 25;6:68. doi: 10.1186/1750-1172-6-68.
The hypobetalipoproteinemias.
Schonfeld G.
Annu Rev Nutr. 1995;15:23-34. doi: 10.1146/annurev.nu.15.070195.000323.
Abetalipoproteinemia.
Weinstein MA, Pearson KD, Agus SG.
Radiology. 1973 Aug;108(2):269-73. doi: 10.1148/108.2.269.
Low LDL cholesterol-Friend or foe?
Hartz J, Hegele RA, Wilson DP.
J Clin Lipidol. 2019 May-Jun;13(3):367-373. doi: 10.1016/j.jacl.2019.05.006. Epub 2019 May 16.
[Neuroacanthocytosis update].
Ichiba M, Nakamura M, Sano A.
Brain Nerve. 2008 Jun;60(6):635-41.
Hypolipidemia.
Malloy MJ, Kane JP.
Med Clin North Am. 1982 Mar;66(2):469-84. doi: 10.1016/s0025-7125(16)31431-6.
Primary hypobetalipoproteinemia as a risk factor for liver complications.
Tan MY, Zhai XL.
J Hepatol. 2024 Sep;81(3):e124. doi: 10.1016/j.jhep.2024.02.034. Epub 2024 Mar 27.
